文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Zoumei Li
发表
Phase I/II Study of MGCD0103, an Oral Isotype-Selective Histone Deacetylase (HDAC) Inhibitor, in Combination with 5-Azacitidine in Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML).
A. Yang, H. Kantarjian, G. Garcia-Manero, 2007 .